Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TORIPALIMAB vs TRALOKINUMAB-LDRM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TORIPALIMAB vs TRALOKINUMAB-LDRM: Safety Overview

Metric TORIPALIMAB TRALOKINUMAB-LDRM
Total FAERS Reports 1,344 4,116
Deaths Reported 65 57
Death Rate 4.8% 1.4%
Hospitalizations 823 239
Average Patient Age 58.0 yrs 50.5 yrs
% Female Patients 24.9% 61.8%
Manufacturer Coherus Oncology, Inc. N/A
Route INTRAVENOUS N/A